Shambhavi, S. et al. 2025. Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis. World Journal of Oncology. 16, 4 (Jul. 2025), 331–341. DOI:https://doi.org/10.14740/wjon2613.